Literature DB >> 8073815

Psoriasis and endothelins.

G Trevisan1, G Stinco, C Giansante, N Fiotti, P Vidimari, F Kokelj.   

Abstract

BACKGROUND: Psoriasis is characterized by an abnormal proliferation and increased turnover of keratinocytes, the presence of acute and chronic inflammatory cells and microangiopathic changes. Endothelins are a family of peptides which have been investigated especially for their effects on the cardiovascular system. Recent studies have demonstrated their involvement also in human skin. AIM OF THE STUDY: We evaluated the Endothelin-1 and 2 plasma levels in psoriatic patients, as endothelin-1 can be produced in vitro by keratinocytes and can stimulate the proliferation of fibroblasts as well as modify the skin microcirculation dynamics. PATIENTS AND METHODS: We studied 30 patients: 10 affected with psoriasis (PASI from 5 to 10), 10 affected with cardiovascular diseases and 10 healthy controls. The Endothelin-1 and 2 plasma levels were evaluated by radio-immunoassay procedure.
RESULTS: A significant increase in Endothelin-1 and 2 plasma levels was observed in the psoriatic patients, in comparison with the controls.
CONCLUSIONS: Our data seem to suggest a possible relationship between psoriasis and increased plasma level of endothelin-1 and 2, though the possible role played in the pathogenesis of psoriasis needs further studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073815

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  2 in total

1.  G-231A and G+70C Polymorphisms of Endothelin Receptor Type-A Gene could Affect the Psoriasis Area and Severity Index Score and Endothelin 1 Levels.

Authors:  Gökhan Okan; Zeynep Yıldız; Gonca Gökdemir; Eda Yorulmaz; Pervin Vural; Semra Doğru-Abbasoğlu; Müjdat Uysal
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

2.  Cardiovascular findings in patients with psoriasis.

Authors:  Serap Oztürkcan; Aylin Türel Ermertcan; Cevat Sekuri; Bülent Kýlýççýoğlu
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.